OBJECTIVE: The objective was to determine if cyproterone acetate (CPA) therapy for hirsute women demonstrated a dose response. DESIGN: A double-blind dose-ranging study of the effect of 3 doses of cyproterone acetate for a period of 12 months. PATIENTS: Twenty-one hirsute women received the Dianette contraceptive pill (35 micrograms ethinyl oestradiol + 2 mg CPA, Schering Healthcare, UK), 20 received Dianette plus 20 mg CPA and 19 received Dianette plus 100 mg CPA: supplementary CPA was administered on days 1-10 of the birth control pill cycle as described by Hammerstein. MEASUREMENTS: Hair growth was measured using the clinical scale of Ferriman and Gallwey and by direct measurement of hair shaft diameter and linear growth of hair on the f...
Polycystic ovary syndrome is the most common endocrinological problem associated with hirsutism. The...
International audience1. Estrogen plus progestin contraceptives (EPP) are the first-line treatment o...
Objective: To evaluate the effect of oral contraceptive on the serum free prostatic specific antigen...
Objective: To compare the efficacy of two antiandrogens, cyproterone acetate (CPA) and spironolacton...
The aim of this study was to compare the clinical efficacy and safety of low dose cyproterone acetat...
OBJECTIVE: To compare the effectiveness of cyproterone acetate, finasteride, and spironolactone in t...
Purpose: It is aimed to evaluate the efficiency of anti-androgenic drug therapy regiments including ...
OBJECTIVE: To compare the clinical efficacy of an original combined therapy with cyproterone acetate...
WOS: 000182520400004PubMed ID: 12866746The aim of the present study was to evaluate the effects of t...
PubMedID: 12866746The aim of the present study was to evaluate the effects of three different anti-a...
Combined oral contraceptives (COCs) are considered the first-line treatment for women with hirsutism...
Introduction: Hirsutism is a condition characterized by excess hair growth on the face, chest, and/o...
The aim of the present study was to evaluate the effects of three different anti-androgenic drug-the...
Introduction: Hyperandrogenism affects approximately 10-20% of women of reproductive age. Hyperandro...
Hirsutism is a common endocrinological disorder and extremely distressing cosmetic condition in wome...
Polycystic ovary syndrome is the most common endocrinological problem associated with hirsutism. The...
International audience1. Estrogen plus progestin contraceptives (EPP) are the first-line treatment o...
Objective: To evaluate the effect of oral contraceptive on the serum free prostatic specific antigen...
Objective: To compare the efficacy of two antiandrogens, cyproterone acetate (CPA) and spironolacton...
The aim of this study was to compare the clinical efficacy and safety of low dose cyproterone acetat...
OBJECTIVE: To compare the effectiveness of cyproterone acetate, finasteride, and spironolactone in t...
Purpose: It is aimed to evaluate the efficiency of anti-androgenic drug therapy regiments including ...
OBJECTIVE: To compare the clinical efficacy of an original combined therapy with cyproterone acetate...
WOS: 000182520400004PubMed ID: 12866746The aim of the present study was to evaluate the effects of t...
PubMedID: 12866746The aim of the present study was to evaluate the effects of three different anti-a...
Combined oral contraceptives (COCs) are considered the first-line treatment for women with hirsutism...
Introduction: Hirsutism is a condition characterized by excess hair growth on the face, chest, and/o...
The aim of the present study was to evaluate the effects of three different anti-androgenic drug-the...
Introduction: Hyperandrogenism affects approximately 10-20% of women of reproductive age. Hyperandro...
Hirsutism is a common endocrinological disorder and extremely distressing cosmetic condition in wome...
Polycystic ovary syndrome is the most common endocrinological problem associated with hirsutism. The...
International audience1. Estrogen plus progestin contraceptives (EPP) are the first-line treatment o...
Objective: To evaluate the effect of oral contraceptive on the serum free prostatic specific antigen...